Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome.

导出 LinkOut

翻译打印收藏纠错

第一作者： Martin,Achleitner

第一单位： Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

作者： Martin,Achleitner ^[1] ; Nina K,Mair ^[2] ; Juliane,Dänhardt ^[1] ; Romina,Kardashi ^[1] ; Milo A,Puhan ^[3] ; Irene A,Abela ^[4] ; Nicole,Toepfner ^[5] ; Katja,de With ^[6] ; Waldemar,Kanczkowski ^[1] ; Natalia,Jarzebska ^[1] ; Roman N,Rodionov ^[1] ; Christine,Wolf ^[5] ; Min Ae,Lee-Kirsch ^[5] ; Charlotte,Steenblock ^[1] ; Benjamin G,Hale ^[7] ; Stefan R,Bornstein ^[8]

作者单位： Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. ^[1] Institute of Medical Virology, University of Zurich, Zurich, Switzerland.;Life Science Zurich Graduate School, ETH and University of Zurich, Zurich, Switzerland. ^[2] Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. ^[3] Institute of Medical Virology, University of Zurich, Zurich, Switzerland.;Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland. ^[4] Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. ^[5] Division of Infectious Diseases, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. ^[6] Institute of Medical Virology, University of Zurich, Zurich, Switzerland. ^[7] Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.;School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.;Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich and University of Zurich, Zurich, Switzerland. ^[8]

关键词 COVID-19 autoantibodies interferon post–COVID-19 syndrome

DOI 10.1093/ofid/ofad641

PMID 38179103

发布时间 2024-10-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Open forum infectious diseases

2024年11卷1期

ofad641页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome.

Open forum infectious diseases

相似文献

Open forum infectious diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 Syndrome.

Open forum infectious diseases

相似文献

Open forum infectious diseases

相关期刊

检索历史清除